These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8501751)

  • 1. Deflazacort in juvenile chronic arthritis.
    Loftus JK; Reeve J; Hesp R; David J; Ansell BM; Woo PM
    J Rheumatol Suppl; 1993 Apr; 37():40-2. PubMed ID: 8501751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
    Rudge S; Hailwood S; Horne A; Lucas J; Wu F; Cundy T
    Rheumatology (Oxford); 2005 Jun; 44(6):813-8. PubMed ID: 15695300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis--a prospective one year followup study.
    Kotaniemi A; Savolainen A; Kröger H; Kautiainen H; Isomäki H
    J Rheumatol; 1998 Dec; 25(12):2450-5. PubMed ID: 9858444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids.
    Reeve J; Loftus J; Hesp R; Ansell BM; Wright DJ; Woo PM
    J Rheumatol; 1993 Jul; 20(7):1189-95. PubMed ID: 8371216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis.
    Felin EM; Prahalad S; Askew EW; Moyer-Mileur LJ
    Arthritis Rheum; 2007 Mar; 56(3):984-94. PubMed ID: 17328076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.
    Lovell DJ; Glass D; Ranz J; Kramer S; Huang B; Sierra RI; Henderson CJ; Passo M; Graham B; Bowyer S; Higgins G; Rennebohm R; Schikler KN; Giannini E
    Arthritis Rheum; 2006 Jul; 54(7):2235-42. PubMed ID: 16802360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
    Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
    Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and turnover in children with systemic juvenile chronic arthritis.
    Brik R; Keidar Z; Schapira D; Israel O
    J Rheumatol; 1998 May; 25(5):990-2. PubMed ID: 9598904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
    Bello L; Gordish-Dressman H; Morgenroth LP; Henricson EK; Duong T; Hoffman EP; Cnaan A; McDonald CM;
    Neurology; 2015 Sep; 85(12):1048-55. PubMed ID: 26311750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
    Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
    Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
    Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.